Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy

Guardado en:

Detalles Bibliográficos
Autores principales:	Federica Cappuccini, Emily Pollock, Irina Redchenko, Benoit J Van den Eynde, James McAuliffe, Hok Fung Chan, Laurine Noblecourt, Ramiro Andrei Ramirez-Valdez, Vinnycius Pereira-Almeida, Yaxuan Zhou, Adrian VS Hill, Carol Sze Ki Leung
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/76ded580fcd1416c91d0e4737e7a092b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:76ded580fcd1416c91d0e4737e7a092b
record_format	dspace
spelling	oai:doaj.org-article:76ded580fcd1416c91d0e4737e7a092b2021-11-04T17:30:07ZHeterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy10.1136/jitc-2021-0032182051-1426https://doaj.org/article/76ded580fcd1416c91d0e4737e7a092b2021-09-01T00:00:00Zhttps://jitc.bmj.com/content/9/9/e003218.fullhttps://doaj.org/toc/2051-1426Federica CappucciniEmily PollockIrina RedchenkoBenoit J Van den EyndeJames McAuliffeHok Fung ChanLaurine NoblecourtRamiro Andrei Ramirez-ValdezVinnycius Pereira-AlmeidaYaxuan ZhouAdrian VS HillCarol Sze Ki LeungBMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 9 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Federica Cappuccini Emily Pollock Irina Redchenko Benoit J Van den Eynde James McAuliffe Hok Fung Chan Laurine Noblecourt Ramiro Andrei Ramirez-Valdez Vinnycius Pereira-Almeida Yaxuan Zhou Adrian VS Hill Carol Sze Ki Leung Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy
format	article
author	Federica Cappuccini Emily Pollock Irina Redchenko Benoit J Van den Eynde James McAuliffe Hok Fung Chan Laurine Noblecourt Ramiro Andrei Ramirez-Valdez Vinnycius Pereira-Almeida Yaxuan Zhou Adrian VS Hill Carol Sze Ki Leung
author_facet	Federica Cappuccini Emily Pollock Irina Redchenko Benoit J Van den Eynde James McAuliffe Hok Fung Chan Laurine Noblecourt Ramiro Andrei Ramirez-Valdez Vinnycius Pereira-Almeida Yaxuan Zhou Adrian VS Hill Carol Sze Ki Leung
author_sort	Federica Cappuccini
title	Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy
title_short	Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy
title_full	Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy
title_fullStr	Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy
title_full_unstemmed	Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy
title_sort	heterologous prime-boost vaccination targeting mage-type antigens promotes tumor t-cell infiltration and improves checkpoint blockade therapy
publisher	BMJ Publishing Group
publishDate	2021
url	https://doaj.org/article/76ded580fcd1416c91d0e4737e7a092b
work_keys_str_mv	AT federicacappuccini heterologousprimeboostvaccinationtargetingmagetypeantigenspromotestumortcellinfiltrationandimprovescheckpointblockadetherapy AT emilypollock heterologousprimeboostvaccinationtargetingmagetypeantigenspromotestumortcellinfiltrationandimprovescheckpointblockadetherapy AT irinaredchenko heterologousprimeboostvaccinationtargetingmagetypeantigenspromotestumortcellinfiltrationandimprovescheckpointblockadetherapy AT benoitjvandeneynde heterologousprimeboostvaccinationtargetingmagetypeantigenspromotestumortcellinfiltrationandimprovescheckpointblockadetherapy AT jamesmcauliffe heterologousprimeboostvaccinationtargetingmagetypeantigenspromotestumortcellinfiltrationandimprovescheckpointblockadetherapy AT hokfungchan heterologousprimeboostvaccinationtargetingmagetypeantigenspromotestumortcellinfiltrationandimprovescheckpointblockadetherapy AT laurinenoblecourt heterologousprimeboostvaccinationtargetingmagetypeantigenspromotestumortcellinfiltrationandimprovescheckpointblockadetherapy AT ramiroandreiramirezvaldez heterologousprimeboostvaccinationtargetingmagetypeantigenspromotestumortcellinfiltrationandimprovescheckpointblockadetherapy AT vinnyciuspereiraalmeida heterologousprimeboostvaccinationtargetingmagetypeantigenspromotestumortcellinfiltrationandimprovescheckpointblockadetherapy AT yaxuanzhou heterologousprimeboostvaccinationtargetingmagetypeantigenspromotestumortcellinfiltrationandimprovescheckpointblockadetherapy AT adrianvshill heterologousprimeboostvaccinationtargetingmagetypeantigenspromotestumortcellinfiltrationandimprovescheckpointblockadetherapy AT carolszekileung heterologousprimeboostvaccinationtargetingmagetypeantigenspromotestumortcellinfiltrationandimprovescheckpointblockadetherapy
_version_	1718444657887674368

Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy

Ejemplares similares